Polymer Factory to Terminate Liquidity Guarantee for Its Shares

Polymer Factory has decided to terminate its agreement with Pareto Securities regarding the liquidity guarantee for the company’s shares. The final day of liquidity-providing trading under the agreement will be January 20, 2026.

The decision aligns with the company’s ongoing evaluation of its capital market activities and aims to streamline administrative and operational processes related to its share trading. Polymer Factory will continue to monitor trading conditions and assess future needs for market-related support.

For more information, please contact:
Mats Wallnér, Acting CEO
Phone: +46 (0) 70 951 95 06
E-mail: mats.wallner@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.